Literature DB >> 23022254

Unique prognostic factors in acral lentiginous melanoma.

Michael E Egger1, Kelly M McMasters, Glenda G Callender, Amy R Quillo, Robert C G Martin, Arnold J Stromberg, Charles R Scoggins.   

Abstract

BACKGROUND: This study was performed to identify clinicopathologic factors associated with survival in acral lentiginous melanoma.
METHODS: A post hoc analysis of a prospective clinical trial and local database was performed in all patients with acral lentiginous melanomas. Multivariate analyses of factors associated with a tumor-positive sentinel lymph node (SLN) biopsy, disease-free survival (DFS), overall survival (OS), and local and in-transit recurrence-free survival (LITRFS) were performed. Kaplan-Meier survival analyses were performed.
RESULTS: Eighty-five patients were identified. Age younger than 59 years and Breslow thickness (BT) of 2.0 mm or greater were independent risk factors for a positive SLN. SLN status was the only independent risk factor for DFS and LITRFS on multivariate analysis. A BT of 2.0 mm or greater was the only independent risk factor for OS. SLN status distinguished differences in DFS, OS, and LITRFS on Kaplan-Meier analysis.
CONCLUSIONS: SLN status is the dominant factor for recurrence and survival in acral lentiginous melanoma. BT and ulceration are less important in this histologic subtype.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23022254     DOI: 10.1016/j.amjsurg.2012.05.013

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

Review 1.  Improving the diagnosis and treatment of acral melanocytic lesions.

Authors:  Maressa C Criscito; Jennifer A Stein
Journal:  Melanoma Manag       Date:  2017-05-19

Review 2.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

3.  Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?

Authors:  Priyanka V Gumaste; Nathaniel H Fleming; Ines Silva; Richard L Shapiro; Russell S Berman; Judy Zhong; Iman Osman; Jennifer A Stein
Journal:  J Natl Compr Canc Netw       Date:  2014-12       Impact factor: 11.908

4.  Enhanced immunohistochemical detection of neural infiltration in primary melanoma: is there a clinical value?

Authors:  Patrick Scanlon; Jaiying Tian; Judy Zhong; Ines Silva; Richard Shapiro; Anna Pavlick; Russell Berman; Iman Osman; Farbod Darvishian
Journal:  Hum Pathol       Date:  2014-04-18       Impact factor: 3.466

5.  Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.

Authors:  Charles M Balch; John F Thompson; Jeffrey E Gershenwald; Seng-Jaw Soong; Shouluan Ding; Kelly M McMasters; Daniel G Coit; Alexander M M Eggermont; Phyllis A Gimotty; Timothy M Johnson; John M Kirkwood; Stanley P Leong; Merrick I Ross; David R Byrd; Alistair J Cochran; Martin C Mihm; Donald L Morton; Michael B Atkins; Keith T Flaherty; Vernon K Sondak
Journal:  Ann Surg Oncol       Date:  2014-02-15       Impact factor: 5.344

6.  Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.

Authors:  C A Castaneda; C Torres-Cabala; M Castillo; V Villegas; S Casavilca; L Cano; J Sanchez; J Dunstan; G Calderon; M De La Cruz; J M Cotrina; H L Gomez; R Galvez; J Abugattas
Journal:  Clin Transl Oncol       Date:  2017-06-02       Impact factor: 3.405

7.  The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.

Authors:  Xiaoting Wei; Di Wu; Hang Li; Rui Zhang; Yu Chen; Hong Yao; Zhihong Chi; Xinan Sheng; Chuanliang Cui; Xue Bai; Zhonghui Qi; Ke Li; Shijie Lan; Lizhu Chen; Rui Guo; Xinyu Yao; Lili Mao; Bin Lian; Yan Kong; Jie Dai; Bixia Tang; Xieqiao Yan; Xuan Wang; Siming Li; Li Zhou; Charles M Balch; Lu Si; Jun Guo
Journal:  Ann Surg Oncol       Date:  2020-04-06       Impact factor: 5.344

8.  Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.

Authors:  Yi-Shuan Sheen; Yi-Hua Liao; Ming-Hsien Lin; Hsien-Ching Chiu; Shiou-Hwa Jee; Jau-Yu Liau; Yih-Leong Chang; Chia-Yu Chu
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

9.  Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.

Authors:  Xiaoting Wei; Di Wu; Yu Chen; Hang Li; Rui Zhang; Hong Yao; Zhihong Chi; Chuanliang Cui; Xue Bai; Lili Mao; Zhonghui Qi; Ke Li; Shijie Lan; Lizhu Chen; Rui Guo; Xinyu Yao; Bin Lian; Yan Kong; Jie Dai; Bixia Tang; Xuan Wang; Jun Guo; Lu Si
Journal:  Br J Dermatol       Date:  2022-03-25       Impact factor: 11.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.